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Abstract. A rat cDNA encoding a 51-kD protein tyro-
sine phosphatase (PTPI) was cloned into a mammalian
expression vector and transfected into normal and
v-src-transformed mouse NIH 3T3 fibroblasts. In the
stable subclones isolated, PTPI expression at the
mRNA level was elevated twofold to 25-fold. The
highest constitutive level of phosphotyrosine-specific
dephosphorylating activity observed without cytotoxic
effects or significant clonal instability was -10-fold
over the endogenous activity. The expressed PTPI was
found to be associated with the particulate fraction of
the fibroblasts. Subcellular fractionation and immuno-
fluorescent microscopic examination of PTPI-overex-
pressing cells has shown the phosphatase to be localized
to the reticular network of the ER . PTPI was readily
solubilized by detergents, but not by high salt. Limited
proteolysis of membrane-associated PTPI resulted in
the release of lower molecular mass (48 and 37 kD)
T
HE phosphorylation of specific tyrosine residues in
cellular proteins is recognized as a critical event in
the regulation ofthe cell cycle and neoPlastic transfor-
mation. Protein tyrosine kinases generate part of the intra-
cellular signal transduction pathway that mediates the bio-
logical response of cells to growth factors and oncogenic
viruses. Protein tyrosine phosphatases (PTPase; I protein-
tyrosine-phosphate phosphohydrolase, EC 3.1.3.48) modu-
late and even attenuate the activities of tyrosine kinases in
addition to functioning in the dephosphorylation of other
specific phosphotyrosine (PTYR)-containing cellular sub-
strates. Thus, the equilibrium established between protein
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forms of the enzyme to the cytosol. Thermal phase
partitioning of isolated membranes with Triton X-114
indicated that the full-length PTPI was strongly inte-
grated into the membrane in contrast to the proteolyti-
cally derived fragments of PTPI. Overexpression of
PTPI caused little apparent change in the rate of cell
proliferation, but did induce changes in fibroblast mor-
phology. A substantial increase in the proportion of
bi- and multinucleate cells in PTPI-expressing cell
populations was observed, and, in the case of the v-src-
transformed cells, cell flattening and loss of refractibil-
ity occurred. Although no apparent difference in the
tyrosine phosphorylation of pp60-rc was noted in
v-src-transformed control and PTPI-overexpressing
fibroblasts, the phosphotyrosine content of a 70-kD
polypeptide was decreased in PTPI-overexpressing
cells.
tyrosine kinases and phosphatases is vital in determining
both the cell growth properties and the differentiation state
of the cell.
There is evidence that certain PTPases may act in a posi-
tive manner to regulate cell cycle progression (12), cell
proliferation (16, 30), and differentiation (11, 18, 40).
PTPases could also act in an opposing manner to inhibit cell
growth, because tyrosine kinases have often been implicated
as positive regulators of cell proliferation. Certain PTPases
may therefore function as potential antioncogenes or sup-
pressors of cell transformation. Protein tyrosine phospha-
lases are potently inhibited in vitro by micromolar concen-
trations of orthovanadate (17, 31, 38). Treatment of intact
cells with noncytotoxic levels of vanadate can induce a re-
versible transformed phenotype and changes in the cytoskel-
etal architecture that are similar to that reported for Rous
sarcoma virus (RSV)-transformed cells (19) . Vanadate has
been shown to mimic the mitogenic effects of certain growth
factors such as EGF, FGF, and IL-3 on intact cells (19, 25,
37,40). Despite the factthat vanadate has multiple biochemi-
cal effects in the cell, the observation thatvanadate treatment
results in an elevation in the tyrosine phosphorylation level
underscores the important regulatory role that PTPases play.
401The elevated PTYR content of at least 20 different polypep-
tides identified by immunoblot analysis indicates that under
such conditions the endogenous activities of at least a subset
oftyrosine phosphatases are suppressed . This allows for spe-
cific PTYR-containing cellular substrates to be shifted to
their phosphorylated forms . Unfortunately, the identity and
role played by many of these proteins is still uncertain .
A rat brain cDNA encoding a 51-kD PTPase has been iso-
lated and characterized in our laboratory (15) . PTPI is a
vanadate- andmolybdate-sensitivephosphatase that is widely
distributed, is highly active, and shows an absolute specific-
ity for PTYRcontaining proteins. PTPI contains a single
catalytic domain in contrastto the integralmembrane protein
receptor-like enzymes such as leukocyte common antigen
(LCA), leukocyte antigen-related (LAR) phosphatase, and
LCA-leukocyte-related phosphatase (LRP) that contain
duplicated PTPase domains (21, 24, 35, 36) . Two other
mammalian, nonreceptor-like tyrosine phosphatases have
been cloned and sequenced : PTPlB, characterized from hu-
man placenta (3, 5, 6) and T cell PTP from human lympho-
cytes (8) . PTPI shares 97% amino acid sequence identity
with humanPTPlB and 72% identity with the core phospha-
tase domain of T cell PTP
In this study, the overexpression ofPTPI transfected into
both normal and v-src-transformed mouse 3T3 fibroblasts
was investigated to determine its subcellular localization and
effectsoncell morphology, cell growth properties, and pattern
of intracellular tyrosine phosphorylation. The transforming
gene (v-src) ofRSV encodes a highly active 60,000-kD pro-
tein tyrosine kinase (pp60"src), which is autoactivating and
capable of phosphorylating a variety of cellular proteins (7) .
Because pp60-rc has been implicated in playing a major
role in the establishment and maintenance of the neoplastic
phenotype (7,22), overexpression ofa PTPase in v-src-trans-
formed fibroblasts provided an interesting model system
to study the effects of tyrosine dephosphorylation induced
by PTPI .
Materials andMethods
Cell Culture and Transfections
NIH 3T3 mouse fibroblasts were routinely grown at lour density at 37°C in
a water-saturated 10% C02/90% air atmosphere inDME (Flow Laborato-
ries, Inc., McLean, VA) supplementedwith 10% (vol/vol) calfserum, peni-
cillin (100 U/ml), and streptomycin (100 pg/ml) . New cultures were started
from frozen stocks every 4-6 wk . The highlytransformedparental NIH 3T3
subline (3T3 JHV2B) was established by initial transfection with a plasmid
containing the v-src gene derived from the PragueA strain of RSV (kindly
provided by Elizabeth Taparowsky, Purdue University, West Lafayette, IN).
3T3 JHV2B was isolated as a singleclone following focus formation in 0.5%
calf serum . Cells were cotransfected with pKO neo, which encodes the
aminoglycosidetransferasegene, and PTPI plasmidDNA using thecalcium
phosphate precipitation method (41) . After 24 h, cells were replated into
medium containing 400 mg/ml geneticin (G418 ; Gibco Laboratories, St.
Lawrence, MA) . Stable neomycin (geneticin)-resistant 3T3 subclones were
isolated at 12-14 d posttransfection and maintained in selective medium.
Expression ofPTPI in Escherichia coli
PTPIcDNA was originally isolated from a rat hypothalamic cDNA library
using a mixed oligonucleotide probe based upon the amino acid sequence
FWEMVWEQK derived from human placenta PTPIB (15) . In addition to
the full-length PTPI used fortransfection studies, a truncated form ofPTPI
(PTP U323) was used for affinity purification of PTPI specific antibody.
This mutated PTPI protein is -37 kD compared to 51 kD for the wild type
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Figure 1. Schematic diagram of the recombinant wild type PTPI
and carboxyl-terminal truncated mutant designated PTPU323 . The
proposed active site in the single PTPase domain encompasses a
region surrounding Cys 215 that has been shown to be essential for
catalysis (14) .
PTPI and more resistant to proteolytic degradation (Fig . 1) . A 1.8-kb
EcoRI-SaII fragment encoding the truncated PTPI was isolated from pT7-
PTP U323 and then ligated into EcoRI/SaII-digested pGEX-KG (13) . This
modified vector allowed the expression of PTPI in frame with a 26-kDa
fragment of glutathione-S-transferase (GST) for purification of the fusion
protein from crude bacterial extracts in a single step by affinity chromatog-
raphy on glutathione agarose . Purification of the GSTPTP U323 fusion
protein was done accordingto Guanand Dixon (13) with modification . Bac-
terial cultures were incubated at 37°C until reaching an A600 of 1 .0. IPTG
was added to 0.2 mM, and cells were harvested by centrifugation after 3 h
ofadditional growth . Bacterial pellets were lysed by vigorous shaking with
0.1-mm glass beads in 50mM imidazole, pH 7.5, 0.5 mM EDTA, 300 mM
NaCl, and 0.1% ß-mercaptoethanol using 25 ml of buffer/liter of culture .
Aftercentrifuginglysates at 10,000g for 10 min at 4°C, the cleared superna-
tant was incubated with a 50% (vol/vol) slurry of glutathione agarose for
2 h at 4°C . The agarose beads were washed with20mM imidazole, pH 7.5,
25 mM NaCl, 0.05% Triton X-100, 10% glycerol, and 0.1% ß-mercapto-
ethanol . The fusion protein was cleaved directly from the resin by incuba-
tion for 20 min at 24°C in thrombin cleavage buffer (20mM imidazole, pH
7.5, 150 mM NaCl, 2 .5 MM CaC12, and 0.1% ß-mercaptoethanol) using
N4pgofthrombin per 2 mg offusionprotein. After centrifuging thesample
at 5,000 g for 5 min at 4°C, purified PTPase was recovered in the superna-
tant. 2 mg of active PTPase protein were routinely isolated from 100 ml
of bacterial culture. After further purification by SDS-PAGE, the 37-kD
PTP U323 protein was used for antibody production.
Production andA ffinity Purification ofPTPI Antibody
Polyclonal antibody to purified PTP U323 protein was generated by subcu-
taneous injection ofa New Zealand white rabbit according to standard pro-
tocol . Serum was mixed with 0.5 vol of saturated ammonium sulfate, and
the suspension was centrifuged at 3,000 g for 30 min . The pellet was
resuspended in PBS and dialyzed against the same buffer at 4°C. For anti-
body purification, the GSTPTP U323 fusion proteinwas bound to activated
Affigel 10 in 0.1 M MOPS, pH 7.5, containing 0.2% ß-mercaptoethanol .
After covalent attachment of GSTPTP U323, the resin was reacted with
0.1 M ethanolamine, pH 8, andwashedwith phosphate buffer. Antibody was
adsorbed to the affinity matrix in 100 mM sodium phosphate, pH 7.6, con-
taining 0.1% Triton X-100, extensively washed, eluted with 0.2M glycine-
HCI, pH 2 .3, containing 0.1 M NaCl and 0.1% Triton X-100, and immedi-
ately neutralized with concentrated Tris-HCl, pH 8 . After the addition of
RIA-grade BSA to 0.2 mg/ml, purified PTPI antibody was concentrated in
0.1 M sodium phosphate, pH 7.2, and stored in 0.02% sodium azide at
-20°C . Western blot analysis was used to verify antibody specificity. Only
a single band migrating at 63 kD (GSTPTP U323 fusion protein) was de-
tected after electrophoretic separation, electrotransfer, and inununoblot
analysis of extracts from bacteria harboring the pGEX-PTP U323 con-
struct .
Construction ofthepCMV-PTPIMammalian
Expression Vectors
PTPI cDNA was subcloned into the mammalian expression vectors,
pCMV4 and pCMV5 (kindly provided by David Russell, Southwestern
Medical Center, Dallas, TX) from which constitutive expression is directed
from the strong cytomegaloviral (CMV) promoter (Fig . 2). pCMV4 con-
tained a translational enhancer sequence corresponding to the 5' untrans-
402lated region ofAlfalfa Mosaic Virus 4RNA positioned so that the enhancer
is located in the 5' untranslated region ofthe mRNA transcribed from the
CMV promoter. This sequence functions by decreasing the initiation factor
requirement for protein synthesis . A 1.4-kb HgaI fragment from pT7-PTPI
(15) encoding the entire PTPI sequence was blunt-ended and ligated into
HindHI-linearized, blunt-ended pCMV4/5, and the correct orientation was
determined by KpnI digestion.
Analysis ofPTPI andpp60- Expression
The levels of PTPI mRNA as well as relative levels of PTPI and pp601'rc
mRNAs in the transfected 3T3 subclones were determined by Northern blot
analysis. Total RNA was prepared by extraction into guanidine isothio-
cyanate, followed by cesium chloride ultracentrifugation . RNA samples (10
Ag/lane) were heat-denatured and electrophoresed on 1.5% formaldehyde
agarose gels, transferred to nitrocellulose, and hybridized at 42°C in 50%
formarnide, 5 x SSPE, 5 x Denhardfs, 0.1% NaDodSO4, and 100 pg/ml
denatured salmon sperm DNA, and radiolabeled probe (1 x 10 6 cpm/ml) .
The PTPI hybridization probewas a 600-bp Xhol fragment from pT7-PTPI
labeled with [32P]dCTP using random primers. The entire pJHv-src plas-
mid was labeled by nick translation for use as a hybridization probe . Both
probes were radiolabeled to a specific activity of2-5 x 108 cpm/pgDNA .
Blots were washed under high stringency (0.1 x SSC, 0.1% SDS) at 65°C
and autoradiographed .
The expression of the PTPI protein was demonstrated by immunoblot
analysis . Trypsinizedcells were washed, pelleted, and boiled in SDS sample
buffer. Whole cell extracts were subjected to electrophoresis on 10%
SDS-polyacrylamide gels and electrotransferred to nitrocellulose (BAg5) .
Filters were incubated with 3 % RIA-grade BSA in TBST (50mM Tris, pH
7.2, 150mM NaCl, 0.5% 'Iween20) at roomtemperature for 4h . For detec-
tion of PTPI, filters were incubated with affinity-purified PTPI antibody
(1:1,000) for 2 h at 4°C and then incubated with 0.1 ACi/ml 1251-labeled
protein A, washed, and exposed toXAR film at -70°C . Alternatively, de-
tection was done using an alkaline phosphatase-conjugated goat anti-rabbit
secondary antibody. The level of pp60"src protein expression was assessed
similarly using mAb EC10 (kindly provided by Tom Parsons, University of
Virginia, Charlottesville, VA), or Mab327 (donated by Joan Brugge, Uni-
versity of Pennsylvania, Philadelphia, PA) and [í 25I]-sheep anti-mouse
IgG .
PTPnseAssay
PTYR-specific phosphatase activity was measured using [32p]-Raytide
(Oncogene Science, Inc ., Manhasset, NY) . The substrate was phos-
phorylated to a specific activity of4-5 x 105 cpm/nmol peptide (N0.2-0.3
mol phosphate/mol peptide) by p43'-ebi tyrosine kinase (Oncogene
Science, Inc.) in the presence of [.y
32P]ATP (3,000 Ci/mmol) . Tyrosine de-
phosphorylation was measured in a 50-id reaction mixture containing 20
mM imidazole, pH 7.0, 5mM EDTA, 20mM sodium fluoride, 0.2 % 0-mer-
captoethanol, and 0.2 pM [ 32p]-tyrosine-phosphorylated substrate . After
incubation for 10 min at 30°C, the reaction was terminated by addition
of 750 iul of activated charcoal solution (0 .9 M HCI, 90 mM sodium
pyrophosphate, 2 mM NaH2PO4 4% (vol/vol) Norit A (35) . The mixture
was microfuged for 2 min, and radioactivity in the supernatant was deter-
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Figure 2 . Mammalian expres-
sion vectors for the establish-
ment of pp60,- and rat PTPI
expression in mouse 3T3 fibro-
blasts . Expression of pp60-rc
and PTPI are under control of
the Moloney murine leukemia
virus LTR (A) and the cyto-
megalovirus promoter (B),
respectively.
mined . Protein concentrations were analyzed according to the Bradford
method (2) . 1 U of PTPase activity is defined as that amount of enzyme
which releases 1 enrol of phosphate per minute. Linearity with respect to
time and protein concentration was verified. Specific phosphatase activities
were corrected for zero time determinations or for control reactions con-
taining all constituents except whole cell or fractionated cell extracts. Be-
causetype2 serine/threonine protein phosphatases, as well asacid phospha-
tases, can dephosphorylate PTYR-containing substrates under certain
conditions, divalent cations were excluded and 5 mM EDTA and 20 mM
NaF were included inthereaction mixture. In addition, contaminatingtyro-
sine dephosphorylating activity of other phosphatases was assessed by con-
ducting PTP assays in the presence and absence of 200 pM sodium
vanadate.
Immunoprecipitations andImmunoblot Analyses with
antipp60-rc and Antiphosphotyrosine Antibodies
Whenmetabolic labelingofcellswas done, cultures were incubated inphos-
phate-free culture medium containing 1% dialyzed FCS and 1 mCi/ml
[32p]-orthophosphate for 12 h . Immunoprecipitation of pp60-' was done
usingmAb 327 or EC10 (kindly provided by J. Brugge, University of Penn-
sylvania, and T. Parsons, University of Virginia, respectively) . Cells were
lysed in RIPA buffer containing 150mM NaCl, 10 mM Tris-HCI, pH 7.4,
5mM EDTA, 1% TritonX-100, 1% sodium deoxycholate, 0.1% SDS, 1 mM
sodium vanadate 15 pM pherrylarsine oxide, 1 mM PMSF, 100 pM apro-
tinin, and 11M leupeptin and then passaged threetimesthrough a 26-gauge
needle. Protein concentrations of lysates were determined using the BCA
protein assay kit (Pierce Chem. Co., Rockford, IL) . Lysates were adjusted
to 1 mg/ml protein and incubated with an excess ofantibody for 2 h at 4°C .
50 pl ofa 1 :3 slurry ofprotein A-Sepharose CL-4B (Pharmacia Diagnostics
Inc ., Fairfield, NJ) previously incubated with rabbit anti-mouse IgG (Ac-
curate Chem. & Sci . Corp., Westbury, NY) was added, and the lysate was
rotated for 1 h at 4°C . Immunoprecipitates were washed three times with
RIPA buffer containing 400mM NaCl, three times with buffer containing
150mM NaCl, and twice with 40mM Tris-HCI, pH 7.2 . All wash buffers
contained 0.2 mM sodium vanadate .
Washedpp60" immunoprecipitates were resuspendnd in 10mM Tris-
HCI, pH 7.2 . For [32p]-labeled samples, or when probing with an anti-
PTYR antibody, extracts were analyzed by 10% SDS-PAGE and subjected
toautoradiography orimmunoblotanalysis followingelectrotransfer tonitro-
cellulose, respectively.
The protein tyrosine kinase assay was performed by resuspending the im-
munoprecipitates in 30 Al ofkinase buffer containing 20mM Tris-HCI, pH
7.2, 5 mM MgC12, 5 pCi[,t32P]ATP (10 mCi/ml ; Amersham Corp.,
Arlington Heights, IL) and 5 iAg of acid-denatured enolase as an exogenous
substrate . The reactions were allowed to proceed at room temperature for
2 min. Samples were electrophoresed asdescribed above, and the gels dried
and subjected to autoradiography .
For immunoblot analysis with and-PTYR antibodies, cell extracts were
prepared by adding lysis buffer (50mM Hepes, pH 7.6, containing 50mM
NaCl, 10% glycerol, 1% Triton X-100, 30 mM sodium pyrophosphate, 50
mM sodium fluoride, 200 p,M sodium orthovanadate, 15pM phenylarsine
oxide, 5mM EDTA, and protease inhibitors) directly toculturedishes, then
incubating on ice for 20 min . Samples were microfuged at 4°C for 5 min .The supernatants were normalized for protein concentration and then
resolved by SDS-PAGE. After electrotransfer to nitrocellulose, filters were
blocked with 3% BSA in TBST (10 mM Tris-HCl, pH 7.5, 150 mM NaCl,
0.5% Tween20), then incubated with a 1:1,000 dilution ofanti-PTYR anti-
body in TBST (mAb Ig2bk, Upstate Biotechnology, Inc., Lake Placid, NY;
or Mab 6G9, kindly provided by Tom Parsons, University of Virginia) fol-
lowed by [1251]-sheep anti-mouse IgG at 1 ACi/ml in TBST. Blots were
washed and subjected to autoradiography.
SubcellularFractionation
Exponentially growing cells were washed three times with PBS, scraped
from culture dishes with a rubber policeman, and collected by centrifuga-
tion at 800 g for 5 min. Initially, cytosolic and total membrane particular
fractions were prepared. Cells were allowed to swell and then lysed by
Dounce homogenization in hypotonic buffer (5 mM Hepes, pH 7.2, 1 mM
MgC12, 5 mM d-merecaptoethanol) containing 0.5 ug/ml each of pepsta-
tin, antipain, leupeptin, and chymostatin, 0.1 mM benzamidine, 1 mm
PMSF, and 15 Pg/nil L-1-chloro-3-[4-tosylamido]-7-amino-2-heptanone
HCl. In the case where the membrane fraction was subsequently treated
with trypsin, these protease inhibitors were ondtted. Nuclei were removed
by centrifugation at 2,000 g, and cell extracts were further centrifuged at
100,000 g for 1 h at 4°C to separate the cytosolic (5100)andtotalmembrane
(P100) fractions. Limited trypsin treatment of the membrane fraction
resuspended in hypotonic buffer followeda time course of 20 min. Aliquots
were taken at designated minute intervals, and the digestions were termi-
natedby the addition of a fivefold excess ofsoybean trypsin inhibitor. Sam-
ples were recentrifuged at 100,000 g and separated into cytosolic and post
trypsin-digested membrane fractions.
For further fractionation of cell extracts, cells were collected and lysed
in hypotonic buffer containing protease inhibitors as described above.
Nuclei were pelleted by centrifugation at 2000 g, and the supernatant was
applied to a two-phase system and centrifuged at 100 g to partition the
plasma membrane to the upper phase (26). The lower phase was then
layered onto a 0.2 M sucrose cushion and centrifuged at 164 g to separate
the ER (upper phase) and mitochondria (lower phase). Standardized
amounts ofprotein for each fractionwere subjected to Western immunoblot
analysis as previously described. Subcellular fractions were analyzed for
purity by EM (data not shown).
7Wton X-114 Partitioning
Triton X-114 extractions were performed according to the methoddescribed
by Bordier (1). Membranes (2 mg/ml protein) were lysed in 200 Pl of 10
mM Tris-HCI, pH 7.4, 1% Triton X-114, 1 mM EDTA, 5 mM 2-mercap-
toethanol, and protease inhibitors at 4°C. The mixture was then layered
onto a 300-Pl cushion of 6% (wt/vol) sucrose, 10 mM Tris-HCl, pH 7.4,
1 mM EDTA, and 0.06% Triton X-114 in a 1.5-ml microfuge tube (Eppen-
dorf Inc., Fremont, CA) and warmed to 30°C with gentle agitation during
whichcloudingofthe solution occurred. The phases wereseparated at room
temperature by centrifugation for 2 min at 300 g. The upper aqueous phase
was reextracted with buffer containing 0.5% Triton X-114 and separated on
the same sucrose cushion. The Triton X-114 detergent pellet was washed
once with buffer in the absence ofdetergent. Both phases were normalized
for protein and detergent concentrations and subjected to immunoblot
analysis.
Immunofluorescence StudiesandMicroscopy
Mouse 3T3 fibroblastswere grownon 12 x 12mm coverslips. Normalfibro-
blasts were synchronized by arresting cells in 0.5% calf serum for 48 h fol-
lowedbytheir release fromquiescence by additionofmedia containing 10%
serum. Cell cycle progression was monitored by measuring [3H]thymidine
incorporation into DNA and by determination of the mitotic index as cells
entered the G2/M phase. Cells were fixed and stained as described below.
All steps were carried out at room temperature. Different cell fixation pro-
cedures were necessary for use of the various antibodies and conjugated
lectins.
For staining with affinity-purified PTPI antibody, cells were fixed for 20
min with 3.7% formaldehyde in PBS (25 mM), and then permeabilized for
3 minwith 0.3 % TritonX-100in PBS. Coverslips were thenrinsed and incu-
bated with PTPI antibody for 45 min. After rinsing, coverslips were incu-
bated with FIM-labeled goat anti-rabbit IgG (Vector Laboratories, Inc.,
Burlingame, CA), rinsed again, and mountedin 4% n-propyl gallate in 10%
PBS/90% glycerol. FITC-conjugated ConAandFIM or TRTTC-conjugated
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wheat germ agglutinin (Vector Laboratories, Inc.) were used as markers for
the RER and Golgi apparatus, respectively (39). Cells were fixed and per-
meabilized as described above, and incubated with the conjugated lectins
for 30 min, rinsed, and mounted. The ER was also visualized by staining
with the lipophilic dye 3,3'-dihexyloxacarbocyanine iodide [DiOC6(3)]
(Molecular Probes, Inc., Eugene, OR) . A stock solution of.DiOC6(3) was
made at 0.5 mg/ml in ethanol and stored protected from light. A working
solution of 2.5 ug/ml was prepared in Dulbecco's phosphate-buffered saline
just before use. Cells were fixed for 10 min in 0.25 % glutaraldehyde in Dul-
becco's phosphate-buffered saline and stained with either DiOCb(3) for 5
min or with PTPI antibody as described above. Coverslips were rinsed,
mounted, and examined immediately.
As a control, bacterially expressed PTPI was used to adsorb affinity-
purifiedPTPI antibody. PTPI antibody was incubated with a 10-fold excess
ofPTP U323 protein for 30 min at 37°C and then stored at 4°C until used.
Stained cells were photographed with a microscope (model Axioskop; Carl
Zeiss, Inc., Thomwood, NY) using a plan-neofluar 100X/1.30 oil objective.
Axioline exciter-barrier filters were used for visualizing FITC and TRIM
fluorescence. Photographic prints were made from slides taken with color
film (Ektachrome 400; Kodak, Rochester, NY).
Results
Expressionofthe51-kDRatPTPI in
Mouse 373Nbroblasts
The full-length rat PTPI cDNA encodes a PTYR-specific
phosphatase that is 432 amino acids in length (Fig. 1). The
single PTPase catalytic domain possesses the signature se-
quence VHCSAGIGRSG characteristic ofthe enzyme-active
site. Within this sequence lies Cys 215, which is proposed
to be essential in catalysis by participating in the formation
of a phosphoenzyme intermediate (14) . The PTPI cDNA
was transfected into both normal 3T3 and v-src-transformed
mouse 3T3 fibroblasts. The potential effects of PTPI overex-
pression on cell morphologyand cell growth properties were
studied. In addition, the cellular distribution of PTPI was ex-
amined for future studies aimed at identifying biological
substrates for PTPl-catalyzed dephosphorylation. Transfor-
mation of the parental NIH 3T3 line was achieved by initial
transfection of cells with a plasmid containing the v-src gene
from the Prague A strain of RSV from which expression of
the oncogene product was under control ofthe Moloney mu-
rine leukemia virus LTR (Fig. 2 A). Subcloning ofthe PTP1
cDNA behind the strong CMV promoter in the pCMV4 or
pCMV5 vectors (Fig. 2 B) allowed for the establishment' f
normal and v-src-transformed 3T3 fibroblast subclones that
constitutively expressed the 51-kD protein tyrosine phospha-
tase. Several hundred neomycin (geneticin)-resistant sub-
clones were generated, of which 30 were selected for analy-
sis ofPTP1 expression atboth the mRNAand protein levels.
The levels of PTP1 mRNA as well as the relative levels of
PTPI and pp60"s- mRNA were determined in transfected
subclones by Northern blot analysis of total cellular RNA.
The levels of PTPI mRNA expression in normal 3T3 fibro-
blast subclones were increased fivefold to 10-fold over the
endogenous level by introduction of the CMV promoter-
driven PTPI vector (Fig. 3 A). Expression levels of the
-2.0-kb rat PTPI mRNA in v-src-transformed 3T3 fibro-
blast subclones were in a rangefrom twofold to 25-fold higher
than levels obtained in PTPl-transfected normal 3T3 sub-
clones (Fig. 3, A and B). The translational-enhancer se-
quence in pCMV4-PTP1 proved to be useful in establishing
stable expression of rat PTPI in normal 3T3 fibroblasts. It
was generally the case that normal 3T3 subclones transfected
404with pCMV5-PTP1 demonstrated an initial high level of rat
PTP1 expression that was subsequently diminished with se-
rial passage of the cells as observed by immunofluorescent
microscopy. The normal 3T3 subclone, CMV4-Z, which
showed stable PTPI expression was selected for further
studies . A series of stable v-src-transformed 3T3 subclones
showing stepwise increases in the level ofPTPI mRNA ex-
pression were also selected for further characterization (Fig .
3 B) . As indicated in Fig . 3 C, these subclones expressed
PTP1 mRNA upon a similar background level of pp60-
mRNA .
Western blot analysis using affinity-purified PTPI anti-
body was used to determinethe level ofPTPI protein expres-
sion in whole cell extracts . Endogenous levels ofPTP1 (or
a similartyrosine phosphatasethatmay have sharedepitopes)
werebarely detectable inneomycin-resistantnormal ortrans-
formed control subclones at low passage number. In PTPl-
transfected subclones, the relative levels of the 51-kD tyro-
sine phosphatase protein reflected the PTPI mRNA levels .
PTPI and pp60- protein expression levels in the trans-
formed control subclone (src neo) and src CMV5-1 PTP, a
transformed PTPI overexpressing subclone, are shown in
Fig. 4 . Vanadate-sensitive PTPase activities were measured
in cell extracts using PIP-Tyr)-Raytide as the substrate . In
the case of src CMV5-7 PTP and src CMV5-1 PT?, PTYR
specific phosphatase activities were increased threefold and
10-fold over the endogenous activity, respectively (Table I) .
Interestingly, the endogenous level of tyrosine phosphatase
activity increased by -30-50% as a consequence of v-src-
induced cell transformation alone . In the PTPl-transfected
Woodford-Thomas et al . Expression ofPTPI in Mouse Fibroblasts
Figure 3 Northern blot anal-
ysis showing PTPI expres-
sion levels in a selected series
of normal and v-src-trans-
formed, pCMV PTP1-trans-
fected mouse 3T3 subclones.
Total RNA (10 ug/lane) iso-
lated from individual sub-
clones was electrophoresed on
a 1.5% formaldehyde gel,
transferred to nitrocellulose
and probed with either radio-
labeled 600-bp Xhol frag-
ment derived from lfT7-PTPI
or radiolabeled pJHv-src.
RNA size markers are indi-
cated . Probes used are indi-
cated below blots . (A) Normal
3T3 neon control subclone
and two representative PTPl-
transfected subclones . (B and
C) v-src-transformed, neon
control subclone and three
v-src-transformed, PTPI-trans-
fected subclones .
normal 3T3 subclones examined, PTPase activities were ele-
vated approximately twofold to threefold over the endog-
enous level .
The growth rate of PTPl-expressing subclones only
showed minor alteration in that the doubling time was in-
creased by 1-2 h . However, certain changes in the morpho-
logical appearance of the mouse fibroblasts were observed.
An increased number ofmultinucleate cells were noted in the
populations of both normal and transformed, PTP1 express-
ing subclones . In these subclones, 2-3% ofthe cells were bi-
or multinucleate . Cells of the src neo control subclone were
rounded, were refractile, showed no indication of growth
saturation at high cell density, and, as such, were highly
transformed (Fig. 5 C) . Cells of the src CMV5-1 PTP ex-
pressing subclone, which synthesized the highest achievable
levels of the 51-kDPTP1 protein, were nonrefractile and re-
sumed amore flattened morphology that was different from
the fusiform cell morphology of the normal cells (Fig . 5, A
and D) . Morphological changes in the srcCMV5-7PTP sub-
clone were intermediate (Fig. 5 B) . The ability of the src
CMV5-1 PTP subclone to grow in low serum (0.2%) was
unaltered by PTPI overexpression . However, preliminary
studies indicated that this subclone had a 75% reduction in
its ability to form colonies whenplated in soft agar, although
the normal plating efficiency ofthe subclone was comparable
to the parental transformed clone (>98%) .
Examination ofPbtential Cellular SubstratesforPTPI
After oncogenic transformation of 3T3 fibroblasts by v-src,
the level ofPTYR in cellular proteins is elevated severalfold
405Figure 4 . Western blot analysis ofPTP1 and pp60"src expression in
the src neo control and src CMV5-1 PTP1 subclones . Total cell ex-
tracts prepared as described in Materials and Methods were re-
solved by 10°ío SDS-PAGE, electrotransferred to nitrocellulose,
and probed with affinity-purified rat PTP1 antibody or antibody to
pp60src (mAb EC10), followed by [251]-protein A or [ 125I]-sheep
anti-mouse IgG, respectively . Protein molecular weight markers
are indicated .
over that found in normal proliferating cells . Therefore, it is
advantageous to use these cells for the examination ofin vivo
substrates for PTPl-catalyzed dephosphorylation . One tyro-
sine phosphorylated protein initially analyzed was pp60-rc
itself. In vitro, PTP1 had the ability to dephosphorylate a
synthetic v-src peptide (RRsrc, RRLIEDAEY_AARG, Penin-
sula labs) which corresponds to the sequence surrounding
Tyr 416, the major autophosphorylation site in pp60-rc (not
shown) . In addition, purified recombinant PTP1 protein
could dephosphorylate native pp60-rc when added to [32P]
autophosphorylated kinase immunoprecipitates. However,
no evidence has been obtained in vivo to suggest that the
transfected rat PTPI can alter the tyrosine phosphorylation
state of pp60- .
When pp60-s- was immunoprecipitated from lysates
from the src neo and srcCMV5-1 PTP subclones andimmu-
noblot analysis performed using anti-PTYR antibody, no
difference was noted (Fig . 6, A and B) . Additionally, meta-
bolic labeling of cells with [32P]orthophosphate, followed
by SDS-PAGE of pp60ws- immunoprecipitates and direct
autoradiography revealed no phosphorylation differences
(Fig . 6 C) . Finally, pp60wrrc immune complex kinase assays
were performed . The levels of pp60V- autophosphoryla-
tion and the phosphorylation ofan exogenous substrate, eno-
lase, were similar with both subclones (not shown) .
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Table I . Characteristics of Control and
PTP1 Overexpressing Cells
Cell line/
￿
Cell morphology/
￿
1?TPase
subclone
￿
growth properties*
￿
activity$
Parental
NIH 3T3
￿
Normal line, cells fusiform, contact
￿
105
inhibited, no growth in soft agar
406
JHV2B
￿
v-src transformed line, cells rounded,
￿
155
refractile, not contact inhibited, good
growth in soft agar
Transfected
3T3 CMV4Z Cells fusiform, contact inhibited, 2-3%
￿
350
bimultinucleate, no growth in soft agar
src neo Cells rounded, refractile, not contact
inhibited, good growth in soft agar
170
src CMV5-1
￿
80% cells flattened, nonrefractile, 2-3%
￿
1,660
bi- or multinucleate, growth in soft agar
reduced by 75%
src CMV5-7
￿
50% cells flattened, nonrefractile, often
￿
485
bi- or multinucleate, growth in soft agar
comparable to src neo
* For soft agar growth experiment, 1 x 104 cells/60-mm dish were plated in
2.5% low melt agarose (Bio-Rad Laboratories) in DME/10% CS overlayed on
5% low melt agarose (FMC) in DME/10% CS . Colonies wereallowed togrow
for 2 wk. Plates were stained with p-iodonitrotetrazolium violet (1 mg/ml) and
then scored .
t PTPase activity was measured in total cell lysates using [° 2P]-Raytide as
described in Materials and Methods . 1 unit of PTPase hydrolyzes 1 nmol of
[ 32P]-Tyr (P) per min .
The observation that pp60- is similarly tyrosine phos-
phorylated in control and PTPl-overexpressing cells implies
that this oncoprotein is not a physiological substrate for rat
PTPL Therefore, this tyrosine kinase is highly active in both
the control and PTPl-transfected 3T3 subclones . Thus, the
repertoire of PTYR-containing proteins induced concomi-
tant with cellular transformation represents a further set of
candidate substrates for PTP1. A comparison of the PTYR
protein pattern was made using the src neo and src CMV5-1
PTP subclones .
Cell lysates prepared in the presence ofphosphatase inhib-
itors were resolved by SDS-PAGE and electroblotted . After
probing with an anti-PTYR antibody, one notable difference
was observed . In the PTP1 overexpressing subclone, the
level oftyrosinephosphorylation was significantly decreased
in a polypeptide migrating at -70kD (Fig . 7) . The identity
ofthis potential substrate of PTPI is currently being sought .
SubcellularLocalization ofPTPI
To examine the subcellular distribution of the expressed 51-
kD PTPI, as well as endogenous immunoreactive PTPase,
cell lysates were prepared from control and PTPl-expressing
cells. Lysates were subjected to high-speed centrifugation to
separate the cytosolic (S100) and membrane (P100) frac-
tions. More than 90% ofthe expressed 51-kD PTP1 protein
sedimented with the P100 fraction from the srcCMV5-1 sub-
clone (Fig . 8 A, lane 1 and Fig . 6 B, lane 1) . Similar results
were obtained using the normal CMV4Z 3T3 subclone (not
shown) . In addition, low levels of an endogenous 51-kD im-
munoreactive protein could be detected in the P100 mem-Figure S. Morphological appearance of transfected 3T3 fibroblast subclones . (A) 3T3 neo control . (B and D) Two different PTP1 over-
expressing v-src-transformed 3T3 subclones, src CMV5-7 PTPI and I CMV5-7 PTPl . (C) src neo control . The photographs were taken
under phase-contrast . Bar, -100 pm .
brane fraction isolated from the src neo control cells upon
prolonged autoradiographic exposure of immunoblots after
using [III]-protein A for detection . The 51-kD PTPI could
be effectively released from the P100 fraction by treatment
with 0.5% Triton X-100/1% CHAPS (Fig . 8 B, lane 4), but
not by salt extraction with 0.6 M KCI . In the case of the
src CMV5-1 PTP subclone, measurement of PTYR-specific
phosphatase activity using 32P-labeled Raytide as the sub-
strate indicated that at least 85% of the enzyme was mem-
brane associated . Incubation ofthe P100 fraction at4"C for
2 h in the absence of added protease inhibitors resulted in
the proteolytic breakdown ofthe full-length 51-kD PTPI first
to a 48-kD form and then to a 37-kD form (Fig . 8 B, lane
2) . This latter molecular weight form comigrated with bac-
terially expressed 37-kD PTP U323, which represents the
mutated PTPI truncated at its COOH-terminal region . The
degradation of PTP1 by a "membrane-associated" protease
that resulted in the formation of the 48- and 37-kD protein
fragments could be mimicked by limited trypsin cleavage of
membrane-associated PTPl . Limited trypsin digestion ofthe
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P100 fraction over a time course of 10 min at30°C resulted
in the generation of similar forms of the phosphatase, of
which the lower molecular weight forms (<51 kD) were pri-
marily released into the cytosol (Fig . 9) .
The cleavage products of PTPI resulting from endogenous
membrane-associated proteolysis or from trypsin digestion
were also examined using thermal phase partitioning . When
either whole cells or the P100 membrane pellet were ex-
tracted with Triton X-114 and the phases partitioned at 30°C,
>90% ofthe expressed 51-kD PTPI was recovered in the de-
tergent phase (Fig . 10) . When the P100 pellet was allowed
to undergo proteolytic breakdown at 4°C or subjected to
limited trypsin proteolysis, the lower molecular weight
forms ofPTPI that were generated partitioned almost exclu-
sively with the aqueous phase .
PTPI Localization Pattern in PTPI-overexpressing
373 Kbroblasts
Staining of PTPi-transfected 3T3 fibroblasts with affinity-
407Figure 6. Analysis ofthe tyrosine phosphorylation state ofpp60wsm
in the src neo and src CMV5-1 PTP subclones . (A) Coomassie
blue staining of pp60-T immunoprecipitates prepared using mAb
327 . (B) Autoradiograph showing the level of phosphotyrosine in
pp60- immunoprecipitates after probing with an anti-PTyr anti-
body. (C) Autoradiograph of pp60"src inummoprecipitates from
32plabeled cells .
purified PTPI antibody indicated that the tyrosine phospha-
tase was associated with a reticular network resembling the
ER . A similar staining pattern was observed for PTPI in
both normal and transformed fibroblasts (Fig . 11, A-C) .
This localization on the ER was supported by use of FITC-
labeled Con A, which recognizes specific mannose-rich car-
bohydrate cores in glycoproteins of the RER (Fig . 11 D) .
In addition, PTPI staining was similar to the image pro-
duced after staining cells with the cationic dye, DiOC6
[DiOC6(3)] (not shown) . Fixation of fibroblasts with 0.25%
glutaraldehyde resulted in the bestpreservation oftheER po-
lygonal network (Fig . 11 B) . The staining pattern observed
after treatment of fixed permeabilized cells with TRITC-
WGA to visualize the Golgi apparatus is shown for compari-
son to the localization pattern ofPTPI (Fig. 11 E) . Lack of
fluorescent staining by PTPI antibody was observed in non-
transfected fibroblasts or in PTPI-transfected cells stained
with PTPI antibody that had been previously adsorbed with
purified PTP U323 protein (Fig . 11 F) .
Additional EvidenceforAssociation ofPTPI with
theER
Cellular membranes from the src neo and src CMV5-1 PTP
subclones were further fractionated into plasma membrane,
ER, and mitochondria-enriched components . Both the en-
dogenous immunoreactive mouse PTPase from the src neo
subclone and the expressed 51-kD rat PTPI from the PTPl-
transfected cells partitioned primarily with the ER-enriched
fraction as determined by immunoblot analysis (Fig . 12) . A
lower level of signal was detected in the mitochondria-
enriched fraction, which, by EM examination, was -30%
contaminated with ER membrane. These results support the
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Figure 7 . Immunoblot analysis ofphosphotyrosine-containing pro-
teins in lysates from the src neo control and src CMV5-1 PTP sub-
clones . Cellular proteins were resolved by 10% SDS-PAGE . After
electrotransfer, the blot was probed with an anti-PTYR antibody,
then [ 125I]-sheep anti-mouse IgG, and autoradiography performed .
Molecular mass markers are indicated .
immunofluorescent localization of PTPI using permeabi-
lized, fixed PTPI-transfected 3T3 fibroblasts, which indi-
cated that the tyrosine phosphatase was associated primarily
with the ER .
Discussion
The constitutive overexpression ofrat PTPI, which shows an
absolute specificity for the dephosphorylation of PTYR-
containing substrates, has been demonstrated in both normal
and v-src-transformed 3T3 fibroblasts . The levels of rat
PTPI mRNA and protein expression achieved in transformed
cells was on average 10-fold higher than in normal cells . This
observation suggested that overexpression of a highly active
tyrosine kinase, pp60-rc, may have allowed for increased
tolerance for rat PTPI overexpression at levels that might
otherwise be cytotoxic to the cells . During the course of es-
tablishing and maintaining stable PTPI-expressing subclones,
the cytotoxic effects ofPTPI overexpression in certain cell
subclones became obvious. This emphasized the fact that un-
aosFigure 8. Membrane localization of the MAD rat PTPI . (A) Im-
munoblot analysis of the particulate (P100) and cytosolic (S100)
fractions from the src CMV5-1 PTPI and src neo subclones . Ali-
quots of each fraction (20 ug protein/lane) were resolved by 10%
SDS-PAGE, electrotransferred to nitrocellulose, and probed with
PTPI antibody, followed by alkaline phosphatase-conjugated goat
anti-rabbit IgG . (B) Immunoblot analysis of the P100 and S100
fractions from src CMV5-1 PTP using PTPI antibody, followed by
[ 1251]-proteinA . Each lane represents the loading of 10 ug protein :
lane 1, 51 kD PTPI associated with the P100 fraction ; lane 2, endo-
genous proteolysis of the 51-kD PTPI after 2 h at 4°C ; lane 3, S100
fraction; lane 4, S100 fraction following pretreatment of the P100
fraction with 0.5% Triton X-100/1% CHAPS .
Figure 9 . Limited trypsin treatment of the P100 fraction isolated
from src CMV5-1 . Membranes derived from 2 x 106 cells were
resuspended in 200 Al of digestion buffer and treated with trypsin
(0.5 ug/ml) for 0, 2, 6, and 10 min at 30°C. Proteolytic reactions
were terminated addition of excess soybean trypsin inhibition and
extracts recentrifuged at 100,000 g to yield the SI00 fragment . Im-
munoblot analysis was performed as described . Protein molecular
weight markers are indicated .
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der normal conditions, cellular tyrosine phosphatase activity
is necessarily tightly regulated .
The highest level of constitutive PTP1 expression was ob-
served in the src CMV5-1 PTPI subclone in which the Vaz+-
sensitive phosphatase activity level was found to be 10-fold
higher than the endogenous activity in the src n6o control
subclone. Initial examination of the src CMV5-1 PTP sub-
clone by immunofluorescence microscopy using affinity-
purified PTPI antibody indicated that >90% of the cells
expressed detectable levels ofPTPI . This high degree of ex-
pression did not appear to be stable in this subclone, how-
ever, as serial passage of this subclone resulted in a reestab-
lishment of the phosphatase equilibrium such that only
-30% of the cell population demonstrated detectable im-
munofluorescent PTPI staining under the cell growth condi-
tions described . This expression level was then maintained
as a characteristic feature ofthis particular subclone . In con-
trast, 60-70% of the cells from the src CMV5-7 PTPI sub-
clone consistently demonstrated PTPI specific immunofluo-
rescent staining . This particular subclone showed a lower
level of PTPI expression and tyrosine phosphatase activity
that was threefold higher than the endogenous activity.
Interestingly, the endogenous level of Val+-sensitive PTP-
ase activity was found to increase 30-50% in the control
cells as a consequence of a v-src transformation alone . This
has also been reported to occur in chicken embryo fibro-
blasts following RSV transformation (27) . In both cases, in-
duction of an endogenous PTPase might have occurred to
allow reestablishment of a tyrosine kinase-phosphatase equi-
librium . The endogenous PTPase level in the src neo control
line also increased as cells were carried to a higher passage
number (>15 passages) . The cell culture conditions were
such that by growing in medium containing 10% serum, se-
lection for a highly transformed phenotype was not main-
tained . At a higher passage number, the src neo subclone
characteristically had a slower growth rate and appeared less
transformed morphologically, i.e ., less rounded, less refrac-
tile. It is, therefore, of interest to determine if a direct corre-
lation exists between the rise in endogenous PTPase activity
and the manifestation of a phenotype which appeared to be
less transformed . Whether this increase inPTPase occurred
at the level ofmRNA or protein expression and/or stabiliza-
tion, or whether this increase was the result ofa gene ampli,
fication event is currently being studied .
That constitutive PTPI overexpression was capable of in-
ducing alterations in cell morphology was best exemplified
by the appearance of the src CMV5-1 PTPI subclone . A flat-
tened cell morphology was observed with the cells spreading
well on a plastic surface in contrast to the less adherent,
more rounded, refractile morphology of the src neo control
subclone . Despite this difference, cytoskeletal staining of
both subclones using FITC-phalloidin demonstrated a simi-
lar disorganization of actin cables characteristic ofthe trans-
formed phenotype (not shown) . Also, no differences in the
serum growth factor requirement of PTPI-expressing and
control transformed subclones was observed (not shown) .
However, the src CMV5-1 PTP subclone showed 75% de-
creased ability to form colonies and proliferate in soft agar.
Another characteristic noted in all PTPI-expressing cell
populations was a higher percentage ofbi- and multinucleate
cells .
The 51-kD PTP1 protein in PTPI-expressing 3T3 fibro-
409blasts was found to be almost entirely membrane-associated
(>85%) as demonstrated by immunoblot analysis in combi-
nation with PTPase activity measurements. Localization of
PTP1 to the membrane network forming the ER was shown
by immunofluorescent microscopy and was further sup-
ported by subcellular fractionation studies in which the 51-
kD PTP1 partitioned primarily with the ER-enriched sub-
fraction . In addition, immunolocalization ofPTPI to the ER
was verified byEM (not shown) . When cells were permeabi-
lized by brieftreatment with 0.3% Triton X-100 before form-
aldehyde fixation, localization ofPTPI to the ER was abol-
ished, most likely because of its solubilization from the
membranes. Ifcells were then stained withFITC-Con A (for
ER imaging) or antitubulin antibodies followed by fluoroscein-
conjugated second antibody, only the microtubular cytoskel-
eton was observed .
It was of concern that the association of overexpressed rat
PTPI with theERmay not have reflected the natural site for
PTP1 localization within the cell, butrather was an abnormal
reflection of the level ofoverexpression itself . This has been
reported to occur during the expression of T cell receptor
components (23), as well as expression to high levels of a
chimeric growth hormone-influenza hemagglutinin protein
(32), and mutant LDL receptors (29) . These proteins were
found to accumulate in an abnormally expanded component
of smooth-surfacedmembrane that was thought to represent
a hypertrophied transitional zone between the ER and the
Golgi complex or else confined to the RER itself and irregu-
lar extensions of the RER . These localizations most likely
reflected the site of blockage in the movement of either
artificial or naturally occurring mutant proteins or unused
components ofmembrane receptor complexes. The rat PTPI
shows 97% amino acid sequence identity with the ubiquitous
PTPlB and is a naturally occurring mammalian tyrosine
phosphatase . It would therefore not likely be recognized as
a foreign protein inmouse cells . Two pieces ofevidence sup-
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Figure 10. Triton X-114 phase
partitioning of the P100 frac-
tion from src CMV5-1. Mem-
branes were allowed to under-
go proteolysis by endogenous
proteases (2 h, 4°C) : T, total
membranes; S, supernatant
(aqueous) ; D, detergent phase ;
or with added trypsin (0.5
Aglml, 10 min, 24°C) : To ,
total membrane fraction, T5 ,
total membrane fraction, 5-min
trypsin digestion; S,o , super-
natant, 10-min trypsin diges-
tion ; D,o, detergent phase,
10-min trypsin digestion . Im-
munoblot analysis was per-
formed as described . Pro-
teinmolecular weightmarkers
are indicated . Bacterially ex-
pressed 37-kD PTPU323 is
shownas anadditionalmarker.
port the contention that PTPI and a similar endogenous im-
munoreactive mouse PTPase are naturally associated with
the ER . First, immunofluorescence microscopic examina-
tion of the normal 3T3 CMV4Z subclone and the trans-
formed src CMV5-7 PTP and src CMV5-1 PTP subclones
gave similar staining patterns. Therefore, the localization of
PTPI was not altered by the level ofPTP1 expression . The
distribution pattern of PTPI was also similar in normal and
v-src-transformed PTPl-expressing subclones even though
their cytoskeletal architecture was quite different . Second, a
similar subcellular distribution was observed by immunoblot
analysis of fractionated membranes from the src neo and src
CMV5-1 PTP1 subclones indicating that rat PTP1 was
colocalized to the same ER-enriched membrane subfraction
as a similar endogenous, immunoreactive mouse PTPase.
The 51-kD PTPI could be detergent solubilized from iso-
lated cell membranes, but could not be extracted with salt
concentrations up to 600mM KCI . This biochemical data
suggests that the PTPase may be integrated into the mem-
brane . Triton X-114 extraction of isolated membranes fol-
lowed by thermal partitioning also demonstrated that >90%
ofthe 51-kDPTPI could be recovered in the detergent pellet,
suggesting that it is an integral membrane protein . This re-
sult agrees well with results from the standard membrane
preparation in that 85-90% of the enzyme activity was as-
sociated with the P100 fraction . Natural degradation of the
particulate MAD PTPI occurred using washed, isolated cell
membranes. It is significant that limited trypsinization of
thesemembranes generated protein fragments of a size simi-
lar to that occurring under endogenous conditions. These
fragments are believed to be generated by proteolysis at the
COOH terminus, because these forms of PTP1 show high
phosphatase activity and it is known the deletion of as few
as 36 amino acids from the NH,; terminus renders the en-
zyme catalytically inactive (K . Guan and J. Dixon, unpub-
lished observations) . Examination of the primary sequence
410Figure 11. Fluorescent staining of NIH 3T3 fibroblasts for PTP1 localization . Cells were stained for PTPI as described . (A and B) src
CMV5-7 PTP subclone, PTPI antibody. (C) 3T3 CMV4Z PTP subclone, PTPI antibody. (D) src CMV5-7 PTP subclone, FITC-ConA .
(E) src CMV5-7 PTPI subclone, FITCWGA . (F) src CMV5-7 PTP subclone stained with PTPI antibody that was preadsorbed with
PTPU323 37-kD protein . Bars : (A, and C-F) 10 p.m ; (B) 5 Am .
reveals a region in which at least one cleavage site is sus-
pected to be located that would generate the 37-kD form .
Within this region occurs a proline-rich stretch (residues
101-113) followed by at least four basic residues that may
provide the structural basis for accessibility and susceptibil-
ity to proteases . The 48- and 37-kD forms of the enzyme did
not appear to be intimately associated with the membrane
and were released into the S100 fraction with a hypotonic
buffer wash . The lower molecular mass 37-kD form comi-
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grated with an authentic truncated, recombinant form of
PTPI in which the carboxyl terminal 110 amino acids have
been eliminated by introduction of a stop codon at amino
acid residue 323 inthe PTPI coding sequence . After thermal
partitioning of Triton X-114 membrane extracts, the lower
molecular mass 48- and 37-kD forms of PTPI were also re-
covered in the aqueous phase and would therefore be bio-
chemically more hydrophilic than the 51-kD PTPL
The purpose of docking of PTPase activity to theER net-work is unknown . Association of PTP1 with the ER may
limit the substrates available to the PTPase and thus would
impose a form of regulation on the active phosphatase. This
ER subcellular localization of PTPI is in contrast to the
transmembrane PTPases that are interpreted to be associated
with the plasma membrane . These two locations suggest that
PTPI and the "receptor-like" PTPases are likely to recognize
a different set of endogenous substrates and perhaps show
different substrate specificity in vivo . The possibility also ex-
ists thatproteolytic cleavage ofPTPI from theERmembrane
occurs in vivo and this may represent an important mecha-
nism for enzyme regulation . Expression of the full-length
51-kD and truncated 37-kD PTP1 proteins in E. coli ren-
ders PTPases that are both catalytically active towards ex-
ogenous [32P-Tyr]-containing artificial substrates such as
Raytide, src peptide erythrocyte band 3, angiotensin, or ly-
sozyme peptide . The 37-kD form of PTPI appears to be
resistant to further proteolysis both in E. coli or in mam-
malian cells .
The results described herein with constitutive PTP1 over-
expression in NIH 3T3 fibroblasts are in contrast to those
reported for the inducible overexpression of the T cell PTP
inBHK cells (9) . The48-kDT cellPTP existed as a compo-
nent of a high molecular mass (>650 kD) complex that
sedimented primarily with a 5,000 g pellet fraction . This
PTPase was inactive in vitro towards exogenous PTYR-
containing substrates unless first pretreated with trypsin,
which generated a 37-kD form of the enzyme. A 37-kD car-
boxyl terminal-truncated form oftheT cell PTP was also ex-
pressed in BHK cells resulting in a redistribution of PTPase
activity to both particulate as well as supernatant fractions
in which the bound enzyme could be released under less
stringent conditions, as well as the generation of an enzyme
which was fully active without trypsin treatment. A 50
reduction in the cell growth rate and morphological changes
such as cell multinucleation were observed . Although the
full-length and truncated forms of theT cell PTP apparently
displayed considerable activity differences in vitro using re-
duced and carbomethylated (RCM) lysozyme as a substrate,
in intact cells analysis of the PTYRcontaining cellular pro-
tein pattern showed little difference.
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Figure 12. Fractionation of
cell extracts prepared from the
src neo and src DMV5-7 PTP
subclones. Subcellular sepa-
ration of membrane fractions
was done in the presence
of protease inhibitors as de-
scribedinMaterialsand Meth-
ods . 5 mg of protein/lane and
2 Kg of protein/lane were re-
solved for fractions derived
from the src neo and src
CMV5-7 PTP subclones, re-
spectively. WC, whole cell ly-
sate ; N, nuclear-enriched ;
ER, ERenriched ; M, mito-
chondria-enriched . Immuno-
blot analysis and detection
of PTPI was performed as
described .
It is thought that PTPI most likely associates with cellular
membranes through its carboxyl terminal tail . The carboxyl
tail of PTPI contains a sequence of amino acids free of
charged residues (residues 408-427) that may participate in
the association ofthe enzyme with theERmembrane . In ad-
dition, this region of PTPI contains a sequence of amino
acids that could be modified by polyisoprenylation or
palmitoylation (15) . Studies are currently underway using
chimeric PTPI C-tail constructs to evaluate the targeting
function of this region of the molecule. The targeting func-
tion for PTPI appears to be contained within the final 25
amino acids of theCOOH terminus (L . Mauro and J. Dixon,
manuscript in preparation) . Alignment of the sequences of
PTPI with two othermammalian PTPases that contain a sin-
gle catalytic domain indicates that these enzymes diverge
primarily in their COOH-terminal sequence (Fig . 13) . The
specific subcellular distribution of PTPIB and T cell PTP
have not been reported, but if subcellular targeting is di-
rected by the C-tail region it may be speculated that at least
PTPI and the T cell PTP could differ in their cellular local-
ization. The function of the C-tail could therefore be specific
to each PTPase isoform examined. These functions could en-
compass the following : (a) to direct PTPase localization ; (b)
to direct PTPase translocation upon cell stimulation ; (c) to
regulateaccessibility to cellular substrates ; and (d) to modu-
lateenzyme activity . In the latter instance, regulation of en-
zyme activity could occur through the shielding of the cata-
lytic center. Another means by which PTPI activity could be
modulated is by phosphorylation . The carboxyl-terminal re-
gion ofthe rat PTPI contains serine residues at positions 335
and 338 and threonine residues at positions 387 and 394
within sequence motifs that form specificity determinants for
casein kinase II-catalyzed phosphorylation (15) . PTPI can
be phosphorylated in vitro on tyrosine(s) by p431-ab' tyrosine
kinase, although the phosphorylation site(s) have yet to be
identified . Purified PTPI can be shown to undergo auto- or
trans-dephosphorylation in vitro (T. A . Woodford-Thomas
and J . E . Dixon, unpublished results) . The effects of these
phosphorylations on enzyme activity are under study.
TheER network is associated with a microtubular network
that forms partofthe cytoskeleton . Association ofPTP1 with
412Figure 13 Alignment of the amino acid sequences of rat brain PTPI (15), human human placental PTPlB (6), and the T cell PTP (8) .
Gaps (hyphens) have been introduced to optimize alignments . The single amino acid code is used . The carboxyl-terminal (C-tail) region
is shown (gray) .
the ER raises the possibility that PTPase activity could be
differentially regulated during the cell cycle orwhen changes
to the cytoskeleton are provoked . During mitosis, when nu-
clear membrane breakdown occurs, the perinuclear arrange-
ment of the ER and the transcending reticular ER network
become disrupted . At this phase of the cell cycle, the ER-
associated PTPI may be redistributed and/or enzymatically
modulated . Immunofluorescent microscopic studies using
synchronized 3T3 fibroblasts suggest a more diffuse pattern
of PTPI staining during theG2/M phase ofthe cell cycle (not
shown) .
Since the subcellular localization of overexpressed rat
PTPI in 3T3 fibroblasts is now known, it should be possible
to more thoroughly study the phosphotyrosine protein pat-
terns in transfected cells . Cell transformation induced by
pp60-rc is mediated by the tyrosine kinase activity that is
intrinsic to this oncoprotein . pp60-rc is located primarily at
the cytoplasmic face of the plasma membrane in transformed
cells (20, 28, 42) . However, a subpopulation of pp60wsrc
demonstrates perinuclear and cytoskeletal localization . In
this study, no detectable differences in the tyrosine phos-
phorylation state or kinase activity of pp60-rc could be
seen in the src neo control and one PTPI-overexpressing src
3T3 subclone. Therefore, the changes in cellular morphol-
ogy seen in these transformed subclones cannot be directly
accounted for by the changes in the activity level of the src
oncoprotein .
Woodford-Thomas et al . Expression of PTPI in Mouse Fibroblasts
Many cellular proteins have been found to contain in-
creased levels ofPTYR in v-src-transformed cells reflecting
the interaction of this tyrosine kinase with both cytoplasmic
and membrane components of the cell (4, 10, 33, 34) . In ad-
dition to its own autophosphorylating ability, other potential
substrates for pp60-rc include p36 (calpactin I), 50- and
120-kD proteins, vinculin, ezrin, talin, GTPase activating
protein (GAP), and the fibronectin receptor. The overexpres-
sion ofPTPI in v-src-transformed 3T3 fibroblasts in which
the protein phosphotyrosine content is significantly elevated
has revealed at least one candidate substrate for specific tyro-
sine dephosphorylation by PTPI . Activation of pp60-- in
3T3 fibroblasts has been shown to stimulate phosphatidyl-
inositol turnover accompanied by an elevation in cellular di-
acylglycerol and downregulation of protein kinase C (43) . It
should prove interesting to study the effects of PTPI over-
expression on this integrated signal transduction network in
v-src-transformed 3T3 fibroblasts .
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